Acuvi AB (ACUVI) - Net Assets
Based on the latest financial reports, Acuvi AB (ACUVI) has net assets worth Skr399.76 Million SEK (≈ $43.02 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr523.76 Million ≈ $56.36 Million USD) and total liabilities (Skr124.00 Million ≈ $13.34 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Acuvi AB assets under control for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr399.76 Million |
| % of Total Assets | 76.33% |
| Annual Growth Rate | 55.55% |
| 5-Year Change | 794.18% |
| 10-Year Change | N/A |
| Growth Volatility | 275.95 |
Acuvi AB - Net Assets Trend (2019–2024)
This chart illustrates how Acuvi AB's net assets have evolved over time, based on quarterly financial data. Check Acuvi AB tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Net Assets for Acuvi AB (2019–2024)
The table below shows the annual net assets of Acuvi AB from 2019 to 2024. For live valuation and market cap data, see Acuvi AB (ACUVI) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Skr435.25 Million ≈ $46.84 Million |
+23.10% |
| 2023-12-31 | Skr353.57 Million ≈ $38.05 Million |
+4.08% |
| 2022-12-31 | Skr339.73 Million ≈ $36.56 Million |
-12.05% |
| 2021-12-31 | Skr386.28 Million ≈ $41.57 Million |
+693.57% |
| 2020-12-31 | Skr48.68 Million ≈ $5.24 Million |
+1.93% |
| 2019-12-31 | Skr47.75 Million ≈ $5.14 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Acuvi AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 9541900000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | Skr546.58 Million | 125.58% |
| Total Equity | Skr435.25 Million | 100.00% |
Acuvi AB Competitors by Market Cap
The table below lists competitors of Acuvi AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Minesto AB
ST:MINEST
|
$42.93 Million |
|
Adaptimmune Therapeutics plc
F:473A
|
$42.94 Million |
|
Shuang-Bang Industrial
TWO:6506
|
$42.94 Million |
|
Oceanpal Inc
NASDAQ:OP
|
$42.95 Million |
|
UBIVELOX Inc
KQ:089850
|
$42.92 Million |
|
Goodyear (Thailand) Public Company Limited
BK:GYT
|
$42.90 Million |
|
AXIOS Sustainable Growth
NYSE:AXAC
|
$42.88 Million |
|
Shian Yih Electronic Industry Co Ltd
TWO:3531
|
$42.88 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Acuvi AB's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 353,572,000 to 435,250,000, a change of 81,678,000 (23.1%).
- Net income of 28,666,000 contributed positively to equity growth.
- New share issuances of 50,066,000 increased equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr28.67 Million | +6.59% |
| Share Issuances | Skr50.07 Million | +11.5% |
| Other Changes | Skr2.95 Million | +0.68% |
| Total Change | Skr- | 23.10% |
Book Value vs Market Value Analysis
This analysis compares Acuvi AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.81x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 3.62x to 0.81x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | Skr3.30 | Skr11.96 | x |
| 2020-12-31 | Skr3.14 | Skr11.96 | x |
| 2021-12-31 | Skr15.91 | Skr11.96 | x |
| 2022-12-31 | Skr13.58 | Skr11.96 | x |
| 2023-12-31 | Skr13.71 | Skr11.96 | x |
| 2024-12-31 | Skr14.76 | Skr11.96 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Acuvi AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.59%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 16.30%
- • Asset Turnover: 0.31x
- • Equity Multiplier: 1.29x
- Recent ROE (6.59%) is above the historical average (-19.19%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -33.32% | -51.83% | 0.52x | 1.24x | Skr-20.69 Million |
| 2020 | -49.47% | -87.93% | 0.46x | 1.23x | Skr-28.95 Million |
| 2021 | -12.39% | -93.03% | 0.10x | 1.39x | Skr-86.49 Million |
| 2022 | -28.38% | -52.10% | 0.37x | 1.46x | Skr-130.39 Million |
| 2023 | 1.84% | 3.41% | 0.38x | 1.44x | Skr-28.86 Million |
| 2024 | 6.59% | 16.30% | 0.31x | 1.29x | Skr-14.86 Million |
Industry Comparison
This section compares Acuvi AB's net assets metrics with peer companies in the Electronic Components industry.
Industry Context
- Industry: Electronic Components
- Average net assets among peers: $300,549,360
- Average return on equity (ROE) among peers: -47.41%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Acuvi AB (ACUVI) | Skr399.76 Million | -33.32% | 0.31x | $42.93 Million |
| Acconeer AB (ACCON) | $120.18 Million | -57.03% | 0.08x | $134.22 Million |
| Hanza AB (HANZA) | $1.34 Billion | 15.91% | 1.18x | $881.25 Million |
| Inission AB (publ) (INISS-B) | $111.07 Million | 27.02% | 3.34x | $148.80 Million |
| JonDeTech Sensors (JDT) | $2.90 Million | -343.56% | 0.52x | $2.48 Million |
| NCAB Group (NCAB) | $106.38 Million | 37.89% | 4.21x | $1.35 Billion |
| NOTE AB (NOTE) | $369.22 Million | 19.54% | 1.05x | $442.41 Million |
| Unibap AB (UNIBAP) | $49.09 Million | -31.61% | 0.15x | $8.89 Million |
About Acuvi AB
Acuvi AB provides engineering products for OEM solutions in Sweden and internationally. The company offers linear actuators, which includes Piezo LEGS vacuum capable and non-magnetic linear motors and actuators; linear and rotary stages; microplate robots; rotary piezo legs motors; controlling the actuator/motor; custom linear actuators; custom curved rail systems; and corrosion resistant telesco… Read more